Axogen Inc.


AXGN

Price

13.62


Change

-0.08


High

14.14


Low

13.59


Avg Volume

137,806


PE Ratio

NA


52 Week High

23.94


52 Week Low

11.54



Profile

AxoGen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering . AxoGen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. AxoGen is part of the Sid Martin Biotechnology Incubator. As of 2019, AxoGen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.[citation needed]


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.